Get started
meitshel

CYCN long idea presenation of trial study phase 2

Long
Cyclerion Therapeutics, Inc. (NASDAQ:CYCN)  
meitshel Updated   
NASDAQ:CYCN   Cyclerion Therapeutics, Inc.
Trend Analysis Fundamental Analysis
0
0
trendanalysis fundamental
No investment advice!

I do this only for practicing.

Most Info on the chart.

We had a nice volume bounce on July 22 due to announced presentation of clinical trial study.

The presentation should be held July 26- 30.

I would trade the possible pre run up until the presentation.

The outcome of it is 50 / 50
Comment:
trade failled, wasnt a good idea
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.